{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452203403321"]
[null,null,"Titolo",null,"Heart transplantation [[electronic resource] ] : indications and contradictions, procedures and complications / / Catherine T. Fleming, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Biomedical Books, c2009"]
[null,null,"ISBN",null,"1-60876-591-1"]
[null,null,"Descrizione fisica",null,"1 online resource (313 p.)"]
[null,null,"Collana",null,"Cardiology research and clinical developments series"]
[null,null,"Disciplina",null,"617.4120592"]
[null,null,"Soggetti",null,"Heart - Transplantation"]
[{"$nulls":4},"Heart - Surgery"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"Heart Transplantation: Indications and Contradictions, Procedures and Complications\"\"; \"\"Contents\"\"; \"\"Preface\"\"; \"\"Management of Tricuspid Regurgitation After Cardiac Transplantation\"\"; \"\"Abstract \"\"; \"\"Introduction \"\"; \"\"Pathophysiology of Tricuspid Valve Regurgitation Following Cardiac Transplantation \"\"; \"\"Management of Refractory  Tricuspid Regurgitation \"\"; \"\"Recent Experience with Repairs  and Replacements \"\"; \"\"Repair or Replacement? \"\"; \"\"Preventing Post-Transplant TR \"\"; \"\"Conclusion \"\"; \"\"References \"\""]
[{"$nulls":4},"\"\"Virtual Histology Intravascular Ultrasound in Coronary Allograft Vasculopathy\"\"\"\"References\"\"; \"\"Gene Therapy for Prevention of Acute and Chronic Cardiac Rejection\"\"; \"\"Abstract \"\"; \"\"1. Introduction \"\"; \"\" 2. Antisense Cyclin-Dependent  Kinase (cdk) 2 Kinase ODN \"\"; \"\"3. Antisense Proliferating-Cell  Nuclear Antigen (PCNA) ODN \"\"; \"\"4. Antisense Bcl-x ODN\"\"; \"\"5. E2F Decoy \"\"; \"\"6. NF-kB Decoy \"\"; \"\"7. Summary \"\"; \"\"Acknowledgement\"\"; \"\"References \"\"; \"\"Prevention of Heart Allograft Rejection by Immunotherapy with Ex Vivo-Expanded Foxp3+CD4+CD25+ Natural Regulatory T Cells\"\"; \"\"Abstract\"\""]
[{"$nulls":4},"\"\"Introduction \"\"\"\"Overview of Foxp3+CD4+CD25+ nTreg Cells \"\"; \"\"Foxp3+CD4+CD25+ Treg  Cells and Allograft Rejection \"\"; \"\"Foxp3+CD4+CD25+ Treg  Cells and Allograft Tolerance \"\"; \"\" Rationale for Immunotherapy with Foxp3+CD4+CD25+ nTreg Cells \"\"; \"\"Strategies and Procedures for Ex Vivo Expansion of CD4+CD25+ nTreg Cells \"\"; \"\"Dynamics of Foxp3 Expression  during Ex Vivo Expansion \"\"; \"\"Suppressive Activity in MLR Assays \"\"; \"\"Engraftment, "]
[{"$nulls":4},"Trafficking and  Homing after Adoptive Transfer \"\"; \"\" In Vivo Suppression and Allograft Survival \"\"; \"\"Determinants of in Vivo Therapeutic Efficacy\"\""]
[{"$nulls":4},"\"\"Issues Regarding CD8+CD25+ nTreg Cells \"\"\"\" Generation and Application of  Foxp3+CD4+CD25+ iTreg Cells \"\"; \"\"Challenges to Clinical Application \"\"; \"\"Conclusion \"\"; \"\"References\"\"; \"\"Addressing the Shortage of Donor Cardiac Allografts - Use of Marginal Grafts\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Strategies to Improve Donor Organ Utilization\"\"; \"\"Expanding the Use of Marginal Donor Organs\"\"; \"\" Use of Marginal Cardiac Allografts  for Heterotopic Transplantation \"\"; \"\"Use of Long Ischemic Time  Organs as Marginal Allografts \"\"; \"\"Primary Graft Failure as a Consequence of Marginal Graft Use\"\""]
[{"$nulls":4},"\"\"Older Donors and Cardiac Arrest Donors \"\"\"\"Continuous Perfusion of Donor Organs \"\"; \"\"Conclusion \"\"; \"\"References \"\"; \"\"Dendritic Cell Modulation for Therapeutic Immunoregulation in Heart Transplantation\"\"; \"\"Abstract\"\"; \"\"Introduction \"\"; \"\"Direct and Indirect Allorecognition \"\"; \"\" Dendritic Cell Subsets and Dendritic Cell Maturation in Organ Transplantation \"\"; \"\"Circulating Dendritic Cells in  Human Organ Transplantation \"\"; \"\"Therapeutic Strategies Based on Genetically Modified Dendritic Cells \"\"; \"\"Therapeutic Modulation of  Dendritic Cell Chemoattraction\"\""]
[{"$nulls":4},"\"\"Generation of Regulatory Dendritics Cells \"\""]